Global CRISPR Technology Market Size to Grow USD 11615 Million by 2030 | CAGR of 20%
Category: HealthcareGlobal CRISPR Technology Market Size To Worth USD 11,615 Million By 2030
According to a research report published by Spherical Insights & Consulting, the Global CRISPR Technology Market Size to Grow from USD 2,251.21 Million in 2021 to USD 11,615 Million by 2030 at a Compound Annual Growth Rate (CAGR) of 20% during the forecast period. The governments of many nations all over the globe have contributed considerable sums of money to genomics research throughout the past few years. As a result, the discovery and exploration of innovative CRISPR technologies have been made possible. In addition, the availability of financial aid has made it feasible for government organizations and academic institutions to conduct extensive research in the field of genomic technology. This has been made possible by the availability of funding.
Get more details on this report -
Browse key industry insights spread across 212 pages with 110 market data tables and figures & charts from the report " Global CRISPR Technology Market Size, Share, and COVID-19 Impact Analysis, By Product (Enzymes, Kits and Reagents, Guide RNA, and Other Products), By Application (Biomedical, Agricultural, Industrial, and Other Applications), By End User (Pharmaceutical Companies and Biotechnology Companies, Academics and Government Research Institutes, and Other End Users (CROs, etc.) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030" in detail along with the table of contents https://www.sphericalinsights.com/reports/crispr-technology-market
View a detailed Table of Content here–
The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an essential role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.
The enzymes segment accounts for the largest market size during the forecast period
Based on product, the CRISPR technology Market is categorized into Enzymes, Kits and Reagents, Guide RNA, and Other Products. The enzymes segment accounts for the largest market size during the forecast period. Because of the widespread use of gene technology methods in research, the enzyme segment of the market is particularly dominant.
The biomedical segment to hold a higher CAGR during the forecast period
Based on application, the CRISPR technology Market is categorized into Biomedical, Agricultural, Industrial, and Other Applications. The biomedical segment to hold a higher CAGR during the forecast period. The biomedical applications sector is the most critical market segment. The rising application of CRISPR gene-editing techniques in an expanding number of subfields within the biomedical sciences is a key factor in the increased revenue generated by this market segment.
The Pharmaceutical Companies and Biotechnology Companies segment to hold a higher CAGR during the forecast period
Based on end users, the CRISPR technology Market is categorized into Pharmaceutical Companies and Biotechnology Companies, Academics and Government Research Institutes, and Other End Users (CROs, etc.). The Pharmaceutical Companies and Biotechnology Companies segment to hold higher CAGR during the forecast period. The Pharmaceutical Companies and Biotechnology Companies segment is increasing due to the rise in the research sector.
Get more details on this report -
North America is estimated to account for the highest market share in 2021.
The Global CRISPR Technology Market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. It is anticipated that the CRISPR market in the North American region will experience significant growth during the forecast period due to the numerous benefits associated with the use of CRISPR technology and the numerous technological innovations and product approvals, and policies implemented by the government. The National Cancer Institute published an article in July 2020 titled "How CRISPR Is Changing Cancer Research and Treatment." The article stated that the first trial in the United States to test a CRISPR-made cancer therapy was launched in 2019 at the University of Pennsylvania to determine whether these treatments are safe. The trial's purpose was to determine whether or not these treatments were effective. The study's preliminary findings revealed that therapies based on CRISPR are safe. There was no indication of an immunological reaction to the CRISPR-edited cells, which supported this hypothesis. These kinds of initiatives on the part of the researchers are opening the way for subsequent studies that will use CRISPR technology to solve unmet needs in the medical field. Asia-Pacific to hold a higher CAGR during the forecast period.
Major vendors in the Global CRISPR Technology Market include Thermo Fisher Scientific (U.S.), Merck & Co. Inc. (U.S.), Genscript (U.S.), Sangamo Therapeutics Inc. (U.S.), Integrated DNA Technologies Inc. (U.S.), Lonza (Switzerland), New England Biolabs (U.S.), CRISPR THERAPEUTICS (Switzerland), Mirus Bio LLC (U.S.), Takara Bio Inc. (Japan), Abbott Laboratories (U.S.), Bio-Rad Laboratories Inc. (U.S.).
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Recent Development
- In February 2022, NTLA-2001 will be developed as a single-dose treatment for transthyretin (ATTR) amyloidosis. Intellia Therapeutics Inc. and Regeneron Pharmaceuticals Inc. announced positive interim data from an ongoing Phase 1 clinical study of their lead in vivo genome editing candidate, NTLA-2001.
- In January 2022, The leading CRISPR and microbiome biotechnology company, SNIPR BIOME ApS, made the announcement that the US Food and Drug Administration (FDA) had approved the Investigational New Drug (IND) Application for the first development candidate. This allowed the company to begin the first clinical trial in humans with SNIPR001. The study is expected to commence in the first half of 2022. It will explore the effects of SNIPR001 on the colonization of E. coli in the gut and the safety and tolerability of the treatment in healthy volunteers.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global CRISPR technology market based on the below-mentioned segments:
Global CRISPR Technology Market, By Product
- Enzymes
- Kits and Reagents
- Guide RNA
- Other
Global CRISPR Technology Market, By Application
- Biomedical
- Agriculture
- Industrial
- Others CRISPR
Global CRISPR Technology Market, By End User
- Pharmaceutical Companies and Biotechnology Companies
- Academics and Government Research Institutes
- Others
Global Technology Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?